Herceptin: Breast Cancer Drug Has Best Outcome When Used For One Year, Studies Show
Category: WELLNESS
Consensus forecasts from Thomson Reuters Pharma show analysts see T-DM1 generating sales of $918 million by 2016. (Editing
By Reuters, Reuters, 2012-10-01